Cargando…
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity
Chemical conjugation of polysaccharide to carrier proteins has been a successful strategy to generate potent vaccines against bacterial pathogens. We developed a similar approach for poorly immunogenic malaria protein antigens. Our lead candidates in clinical trials are the malaria transmission bloc...
Autores principales: | Scaria, Puthupparampil V., Chen, Beth, Rowe, Christopher G., Jones, David S., Barnafo, Emma, Fischer, Elizabeth R., Anderson, Charles, MacDonald, Nicholas J., Lambert, Lynn, Rausch, Kelly M., Narum, David L., Duffy, Patrick E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744994/ https://www.ncbi.nlm.nih.gov/pubmed/29281708 http://dx.doi.org/10.1371/journal.pone.0190312 |
Ejemplares similares
-
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
por: Scaria, Puthupparampil V., et al.
Publicado: (2022) -
Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230
por: Scaria, Puthupparampil V., et al.
Publicado: (2019) -
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques
por: Scaria, Puthupparampil V., et al.
Publicado: (2021) -
Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission
por: Rausch, Kelly M., et al.
Publicado: (2023) -
Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice
por: Healy, Sara A., et al.
Publicado: (2021)